Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes

Endocrine Practice

Volumn 7, Issue 5, 2001, Pages 364-369

  Rizvi, A A ^a   Petry, R ^a   Arnold, M B ^a   Chakraborty, M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG FORMULATION; DRUG INFUSION; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONITORING; MORBIDITY; PATIENT EDUCATION; PATIENT SATISFACTION; PATIENT SELECTION; PRACTICE GUIDELINE; PREVENTION; PUMP; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0035443244     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.7.5.364     Document Type: Article

References (28)

1. Insulin pump treatment in insulin-dependent diabetes mellitus: Children, adolescents, and young adults
2. Continuous subcutaneous insulin infusion: A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes
3. Efficacy of insulin pump therapy: Mealtime delivery is the key factor
4. Bolus and supplemental insulin
5. Modern insulin therapy for type 1 diabetes mellitus
6. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia
7. Continuous subcutaneous insulin infusion: A review of its past and its implementation for the future
8. Insulin pump therapy: Acceptable alternative to injection therapy
9. Insulin pump therapy: No longer a fad
10. Insulin lispro in CSII: Results of a double-blind crossover study
11. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
12. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: Improved control with CSII
13. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
14. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy
15. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus
16. Clinical use of the insulin infusion pump in 100 patients with type I diabetes
17. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
18. Pharmacokinetics of continuous subcutaneous insulin infusion
19. Determination of insulin requirements: Excessive insulin dosages common in type 1 diabetes mellitus
20. Hypoglycemia
21. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia
22. Fear of hypoglycemia: Relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus
23. Correlates of hypoglycemic fear in type I and type II diabetes mellitus
24. Continuous subcutaneous insulin infusion for the treatment of diabetic patients with hypoglycemia unawareness
25. Hypoglycemia: The limiting factor in the management of IDDM
26. Education for continuous subcutaneous insulin infusion pump users
27. Continuous subcutaneous insulin infusion
28. Insulin pump therapy: Situations and solutions